Do analysts recommend JYNT or DCGO?

DocGo has a consensus target price of $2.17, suggesting a potential upside of 755.38%. Given DocGo's stronger consensus rating and higher probable upside, analysts clearly believe DocGo is more favorable than Joint. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Joint 1 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.67 DocGo 1 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.20

Which has stronger valuation and earnings, JYNT or DCGO?

Joint has higher earnings, but lower revenue than DocGo. DocGo is trading at a lower price-to-earnings ratio than Joint, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Joint $54.90M 1.85 $2.91M $0.27 26.67 DocGo $322.20M 0.08 -$182.40M -$1.96 N/A

Is JYNT or DCGO more profitable?

Joint has a net margin of 6.49% compared to DocGo's net margin of -65.29%. Joint's return on equity of 12.02% beat DocGo's return on equity. Company Net Margins Return on Equity Return on Assets Joint 6.49% 12.02% 3.47% DocGo -65.29% -40.42% -24.81%

Which has better earnings and valuation, BTMD or DCGO?

biote has higher earnings, but lower revenue than DocGo. DocGo is trading at a lower price-to-earnings ratio than biote, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio biote $192.22M 0.21 $27.05M $0.11 10.18 DocGo $322.20M 0.08 -$182.40M -$1.96 N/A

Is BTMD or DCGO more profitable?

biote has a net margin of 3.19% compared to DocGo's net margin of -65.29%. biote's return on equity of -22.33% beat DocGo's return on equity. Company Net Margins Return on Equity Return on Assets biote 3.19% -22.33% 12.10% DocGo -65.29% -40.42% -24.81%

Do analysts recommend PRPO or DCGO?

DocGo has a consensus target price of $2.17, indicating a potential upside of 755.38%. Given DocGo's stronger consensus rating and higher possible upside, analysts plainly believe DocGo is more favorable than Precipio. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Precipio 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 DocGo 1 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.20

Which has preferable valuation & earnings, PRPO or DCGO?

Precipio has higher earnings, but lower revenue than DocGo. Precipio is trading at a lower price-to-earnings ratio than DocGo, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Precipio $24.05M 1.39 -$360K -$0.64 N/A DocGo $322.20M 0.08 -$182.40M -$1.96 N/A

Is PRPO or DCGO more profitable?

Precipio has a net margin of -4.47% compared to DocGo's net margin of -65.29%. Precipio's return on equity of -8.49% beat DocGo's return on equity. Company Net Margins Return on Equity Return on Assets Precipio -4.47% -8.49% -5.75% DocGo -65.29% -40.42% -24.81%

Do analysts recommend DCGO or RYOJ?

DocGo currently has a consensus price target of $2.17, suggesting a potential upside of 755.38%. Given DocGo's stronger consensus rating and higher probable upside, equities analysts plainly believe DocGo is more favorable than RYOJ. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score DocGo 1 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.20 RYOJ 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better valuation and earnings, DCGO or RYOJ?

RYOJ has lower revenue, but higher earnings than DocGo. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio DocGo $322.20M 0.08 -$182.40M -$1.96 N/A RYOJ $9.34M 3.15 $120K N/A N/A

Is DCGO or RYOJ more profitable?

RYOJ has a net margin of 0.00% compared to DocGo's net margin of -65.29%. RYOJ's return on equity of 0.00% beat DocGo's return on equity. Company Net Margins Return on Equity Return on Assets DocGo -65.29% -40.42% -24.81% RYOJ N/A N/A N/A

DocGo (DCGO) Competitors

$0.25 +0.04 (+18.36%)

Closing price 11/3/2026 04:00 PM Eastern

Extended Trading

$0.25 0.00 (-0.91%)

As of 08:36 AM Eastern

Compare

DCGO vs. JYNT, PARK, BTMD, PRPO, and RYOJ

Should you buy DocGo stock or one of its competitors? DocGo's main competitors and comparable companies include Joint (JYNT), Park Dental Partners (PARK), biote (BTMD), Precipio (PRPO), and RYOJ (RYOJ). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does DocGo compare to Joint?

Joint (NASDAQ:JYNT) and DocGo (NASDAQ:DCGO) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, media sentiment, earnings, profitability, analyst recommendations, risk, institutional ownership and dividends.

DocGo has a consensus target price of $2.17, suggesting a potential upside of 755.38%. Given DocGo's stronger consensus rating and higher probable upside, analysts clearly believe DocGo is more favorable than Joint.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Joint	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67
DocGo	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20

Joint has higher earnings, but lower revenue than DocGo. DocGo is trading at a lower price-to-earnings ratio than Joint, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Joint	$54.90M	1.85	$2.91M	$0.27	26.67
DocGo	$322.20M	0.08	-$182.40M	-$1.96	N/A

Joint has a net margin of 6.49% compared to DocGo's net margin of -65.29%. Joint's return on equity of 12.02% beat DocGo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Joint	6.49%	12.02%	3.47%
DocGo	-65.29%	-40.42%	-24.81%

Joint has a beta of 1.16, meaning that its stock price is 16% more volatile than the broader market. Comparatively, DocGo has a beta of 1.03, meaning that its stock price is 3% more volatile than the broader market.

76.9% of Joint shares are owned by institutional investors. Comparatively, 56.4% of DocGo shares are owned by institutional investors. 30.2% of Joint shares are owned by company insiders. Comparatively, 5.1% of DocGo shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, Joint had 2 more articles in the media than DocGo. MarketBeat recorded 2 mentions for Joint and 0 mentions for DocGo. Joint's average media sentiment score of 0.00 equaled DocGo'saverage media sentiment score.

Company	Overall Sentiment
Joint	Neutral
DocGo	Neutral

Summary

Joint beats DocGo on 10 of the 14 factors compared between the two stocks.

How does DocGo compare to Park Dental Partners?

DocGo (NASDAQ:DCGO) and Park Dental Partners (NASDAQ:PARK) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, earnings, analyst recommendations, dividends, profitability, media sentiment, risk and valuation.

In the previous week, DocGo's average media sentiment score of 0.00 equaled Park Dental Partners'average media sentiment score.

Company	Overall Sentiment
DocGo	Neutral
Park Dental Partners	Neutral

56.4% of DocGo shares are owned by institutional investors. 5.1% of DocGo shares are owned by insiders. Comparatively, 10.6% of Park Dental Partners shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Park Dental Partners has lower revenue, but higher earnings than DocGo. DocGo is trading at a lower price-to-earnings ratio than Park Dental Partners, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DocGo	$322.20M	0.08	-$182.40M	-$1.96	N/A
Park Dental Partners	$244.49M	0.40	-$360K	$1.05	19.33

Park Dental Partners has a net margin of 0.00% compared to DocGo's net margin of -65.29%. Park Dental Partners' return on equity of 0.00% beat DocGo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DocGo	-65.29%	-40.42%	-24.81%
Park Dental Partners	N/A	N/A	N/A

DocGo presently has a consensus price target of $2.17, indicating a potential upside of 755.38%. Park Dental Partners has a consensus price target of $28.50, indicating a potential upside of 40.39%. Given DocGo's higher possible upside, analysts clearly believe DocGo is more favorable than Park Dental Partners.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DocGo	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20
Park Dental Partners	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50

Summary

Park Dental Partners beats DocGo on 9 of the 13 factors compared between the two stocks.

How does DocGo compare to biote?

biote (NASDAQ:BTMD) and DocGo (NASDAQ:DCGO) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, earnings, valuation, risk, institutional ownership, dividends, analyst recommendations and media sentiment.

biote has higher earnings, but lower revenue than DocGo. DocGo is trading at a lower price-to-earnings ratio than biote, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
biote	$192.22M	0.21	$27.05M	$0.11	10.18
DocGo	$322.20M	0.08	-$182.40M	-$1.96	N/A

biote has a net margin of 3.19% compared to DocGo's net margin of -65.29%. biote's return on equity of -22.33% beat DocGo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
biote	3.19%	-22.33%	12.10%
DocGo	-65.29%	-40.42%	-24.81%

In the previous week, biote had 1 more articles in the media than DocGo. MarketBeat recorded 1 mentions for biote and 0 mentions for DocGo. biote's average media sentiment score of 0.68 beat DocGo's score of 0.00 indicating that biote is being referred to more favorably in the media.

Company	Overall Sentiment
biote	Positive
DocGo	Neutral

biote presently has a consensus target price of $2.50, suggesting a potential upside of 123.21%. DocGo has a consensus target price of $2.17, suggesting a potential upside of 755.38%. Given DocGo's higher possible upside, analysts clearly believe DocGo is more favorable than biote.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
biote	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50
DocGo	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20

21.7% of biote shares are held by institutional investors. Comparatively, 56.4% of DocGo shares are held by institutional investors. 32.4% of biote shares are held by insiders. Comparatively, 5.1% of DocGo shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

biote has a beta of 1.73, meaning that its stock price is 73% more volatile than the broader market. Comparatively, DocGo has a beta of 1.03, meaning that its stock price is 3% more volatile than the broader market.

Summary

biote beats DocGo on 12 of the 16 factors compared between the two stocks.

How does DocGo compare to Precipio?

Precipio (NASDAQ:PRPO) and DocGo (NASDAQ:DCGO) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, media sentiment, earnings, analyst recommendations, risk, profitability and valuation.

10.5% of Precipio shares are owned by institutional investors. Comparatively, 56.4% of DocGo shares are owned by institutional investors. 16.6% of Precipio shares are owned by insiders. Comparatively, 5.1% of DocGo shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

DocGo has a consensus target price of $2.17, indicating a potential upside of 755.38%. Given DocGo's stronger consensus rating and higher possible upside, analysts plainly believe DocGo is more favorable than Precipio.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Precipio	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
DocGo	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20

Precipio has higher earnings, but lower revenue than DocGo. Precipio is trading at a lower price-to-earnings ratio than DocGo, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Precipio	$24.05M	1.39	-$360K	-$0.64	N/A
DocGo	$322.20M	0.08	-$182.40M	-$1.96	N/A

Precipio has a beta of 1.45, meaning that its share price is 45% more volatile than the broader market. Comparatively, DocGo has a beta of 1.03, meaning that its share price is 3% more volatile than the broader market.

Precipio has a net margin of -4.47% compared to DocGo's net margin of -65.29%. Precipio's return on equity of -8.49% beat DocGo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Precipio	-4.47%	-8.49%	-5.75%
DocGo	-65.29%	-40.42%	-24.81%

In the previous week, Precipio had 4 more articles in the media than DocGo. MarketBeat recorded 4 mentions for Precipio and 0 mentions for DocGo. DocGo's average media sentiment score of 0.00 beat Precipio's score of -0.50 indicating that DocGo is being referred to more favorably in the news media.

Company	Overall Sentiment
Precipio	Negative
DocGo	Neutral

Summary

Precipio beats DocGo on 9 of the 15 factors compared between the two stocks.

How does DocGo compare to RYOJ?

DocGo (NASDAQ:DCGO) and RYOJ (NASDAQ:RYOJ) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, valuation, media sentiment, analyst recommendations, profitability, dividends, institutional ownership and risk.

DocGo has a beta of 1.03, suggesting that its stock price is 3% more volatile than the broader market. Comparatively, RYOJ has a beta of 4.77, suggesting that its stock price is 377% more volatile than the broader market.

RYOJ has a net margin of 0.00% compared to DocGo's net margin of -65.29%. RYOJ's return on equity of 0.00% beat DocGo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DocGo	-65.29%	-40.42%	-24.81%
RYOJ	N/A	N/A	N/A

In the previous week, RYOJ had 2 more articles in the media than DocGo. MarketBeat recorded 2 mentions for RYOJ and 0 mentions for DocGo. RYOJ's average media sentiment score of 1.98 beat DocGo's score of 0.00 indicating that RYOJ is being referred to more favorably in the news media.

Company	Overall Sentiment
DocGo	Neutral
RYOJ	Very Positive

DocGo currently has a consensus price target of $2.17, suggesting a potential upside of 755.38%. Given DocGo's stronger consensus rating and higher probable upside, equities analysts plainly believe DocGo is more favorable than RYOJ.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DocGo	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20
RYOJ	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

56.4% of DocGo shares are held by institutional investors. 5.1% of DocGo shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

RYOJ has lower revenue, but higher earnings than DocGo.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DocGo	$322.20M	0.08	-$182.40M	-$1.96	N/A
RYOJ	$9.34M	3.15	$120K	N/A	N/A

Summary

RYOJ beats DocGo on 8 of the 14 factors compared between the two stocks.

Get DocGo News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DCGO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

DCGO vs. The Competition

Export

Metric	DocGo	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$21.17M	$10.50B	$7.79B	$12.08B
Dividend Yield	N/A	2.57%	2.48%	4.42%
P/E Ratio	N/A	41.17	37.51	30.72
Price / Sales	0.08	2.29	8.87	5.87
Price / Cash	3.87	23.31	21.63	22.81
Price / Book	0.20	4.14	4.71	4.05
Net Income	-$182.40M	$318.16M	$3.50B	$381.51M
7 Day Performance	-9.50%	-0.83%	-2.30%	-2.44%
1 Month Performance	-31.45%	-0.05%	-5.38%	-7.02%
1 Year Performance	-75.17%	16.55%	1.17%	-5.71%

DocGo Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
DCGO DocGo	2.9599 of 5 stars	$0.25 +18.4%	$2.17 +755.4%	-75.4%	$21.17M	$322.20M	N/A	3,568	Upcoming Earnings High Trading Volume
JYNT Joint	1.222 of 5 stars	$7.03 -4.5%	N/A	-8.4%	$104.09M	$54.90M	49.07	330	Upcoming Earnings
PARK Park Dental Partners	3.1722 of 5 stars	$21.09 +5.1%	$28.50 +35.1%	N/A	$95.39M	$244.49M	N/A	1,212	High Trading Volume
BTMD biote	4.6623 of 5 stars	$1.11 -5.1%	$2.50 +125.2%	-60.4%	$42.03M	$192.22M	3.44	223	News Coverage Gap Up
PRPO Precipio	0.6815 of 5 stars	$18.10 -6.5%	N/A	-9.5%	$34.64M	$24.05M	N/A	71	Upcoming Earnings Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:DCGO) was last updated on 11/4/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

DocGo (DCGO) Competitors